Tetra Bio-Pharma Inc.
TBP
Rank in Stocks
#35460
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Share Price
$0.01851783
Last synced: 2023-05-23
Market Cap
$3.71M
Change (1 day)
-0.04%
Change (1 year)
1,443.15%
Country
CA
Trade Tetra Bio-Pharma Inc. (TBP)
Category
Healthcare
Market Capitalization of Tetra Bio-Pharma Inc.(TBP)
Market Cap: $3.71M
As of October 2026 Tetra Bio-Pharma Inc. has a market cap of $3.71M. This makes Tetra Bio-Pharma Inc. the world's 35460th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Tetra Bio-Pharma Inc. from 2011 to 2026
TBP compared with Top 5 Most Popular stocks
